Literature DB >> 8695045

The muscarine antagonist methscopolamine and the NMDA antagonist AP-5 injected unilaterally into the nucleus accumbens cause mice to rotate in opposite directions.

A Svensson1, M L Carlsson.   

Abstract

Previously, we have reported that the NMDA antagonist AP-5, injected unilaterally into the nucleus accumbens of mice, induces ipsilateral rotation in monoaminergically intact mice, but contralateral rotation in monoamine-depleted animals. In this paper we report that the muscarine antagonist methscopolamine, injected unilaterally into the nucleus accumbens, induced predominantly contralateral rotation in monoaminergically intact mice. In monoamine-depleted animals intra-accumbens methscopolamine induced only a weak stimulation of rotational behaviour (not significant), but the direction of the rotation was exclusively contralateral, and the animals showed contralateral body deviation. Moreover, when these animals received additional treatment with the alpha-adrenergic agonist clonidine, which potentiates the motor effects of cholinergic antagonists in monoamine-depleted mice (Carlsson et al., 1991), a clear-cut contralateral rotation was induced. The observed behavioural effects are discussed in relation to the positive and negative feedback circuits, which link the nucleus accumbens with the cerebral cortex and thalamus. In previous papers, we have suggested that the ipsilateral rotation induced by AP-5 is mediated primarily by the positive feedback circuit, whereas the AP-5-induced contralateral rotation is due to interference with primarily the negative feedback circuit. Applying this reasoning to the rotational effects of methscopolamine, it seems that methscopolamine interferes primarily with the negative feedback circuit.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8695045     DOI: 10.1007/bf01271552

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  17 in total

1.  Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice.

Authors:  A Svensson; M L Carlsson; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain.

Authors:  J H Meador-Woodruff; A Mansour; D J Healy; R Kuehn; Q Y Zhou; J R Bunzow; H Akil; O Civelli; S J Watson
Journal:  Neuropsychopharmacology       Date:  1991-12       Impact factor: 7.853

3.  MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease.

Authors:  M Morelli; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1990-07-17       Impact factor: 4.432

Review 4.  New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata.

Authors:  G F Alheid; L Heimer
Journal:  Neuroscience       Date:  1988-10       Impact factor: 3.590

Review 5.  Striatal inhomogeneities and basal ganglia function.

Authors:  J B Penney; A B Young
Journal:  Mov Disord       Date:  1986       Impact factor: 10.338

6.  Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice.

Authors:  M Carlsson; A Svensson; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

7.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.

Authors:  C R Gerfen; T M Engber; L C Mahan; Z Susel; T N Chase; F J Monsma; D R Sibley
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

8.  Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801.

Authors:  P Goodwin; B S Starr; M S Starr
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1992

9.  Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene.

Authors:  C Le Moine; E Normand; B Bloch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

10.  Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice.

Authors:  A Svensson; A Carlsson; M L Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.